February 27, 2020

Twice-rejected Barhemsys finally gets its nod

October 31, 2018

Go or no go? Big decisions for Acelrx, Trevena, Loxo and Astellas

Pain drugs look like they could face different outcomes, while targeted cancer agents will have a big month. Two biosimilar decisions also await.

May 24, 2018

Are small companies carrying the complete response letter can?

May 10, 2018

Cosmo’s shares saved by no bell as FDA halts approval

October 06, 2014

Acquisitions help define performance of mid and small cap stocks

September 23, 2014

Salix and Auxilium reveal an anti-chain in overdrive

September 23, 2014

New US anti-inversion rules spark investor flight

July 17, 2014

Ruconest approved but will have to distinguish itself in a crowded space

July 11, 2014

Upcoming events: Alzheimer’s conference and US action on Ruconest